Found: 1
Select item for more details and to access through your institution.
The first-in-class BMI-1 modulators PTC-028 and PTC596 display potent activity in pre-clinical models of multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e113, doi. 10.1016/j.clml.2019.09.188
- By:
- Publication type:
- Article